Testing a new injection in healthy adults in China
Treatments studied
This is an early-stage study testing a new medicine called GR2301 given as multiple injections. Researchers want to see how safe it is and how the body handles it in healthy volunteers with no serious medical conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are in good general health with no significant medical history (nervous system, heart, kidney, stomach, lung, hormone, or metabolic disorders)
- Your weight is at least 50 kg if male or 45 kg if female
- Your BMI (body mass index) is between 19.0 and 28.0
- You are not pregnant, breastfeeding, or planning to become pregnant during the trial
- You have no history of drug or substance abuse, and test negative for drugs before starting
- You understand the trial requirements and voluntarily sign the consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new injection called GR2301 to see if it is safe in healthy people. Volunteers will help researchers understand any side effects before the drug is given to patients with a disease.
This trial tests a new drug called GR2303 to see if it is safe and how the body processes it. It is for healthy adults who have not used similar drugs before.
This is an early-stage safety study testing a new injectable medication (GenSci155) that affects growth and metabolism. Researchers want to make sure it's safe and well-tolerated in healthy volunteers before testing it in patients with medical conditions.
This trial tests an investigational injection called SYH2062 in healthy adults to see if it's safe. It helps researchers understand how the drug affects the body before testing in patients.
This study tests a new injection called GenSci164 in healthy adults. It helps find out how the drug works in the body and if it is safe. Participants receive the injection and are monitored for effects.
This study tests a new injection called LX22001 in healthy volunteers to see how it is processed in the body and if it is safe. It is a first-in-human trial, so you must be in good health and meet specific age, weight, and lifestyle requirements.
Hear when a new Multiple Dose trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.